| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5583267 | Journal of Critical Care | 2017 | 8 Pages |
Abstract
TRI in Q4, as compared to Q1-3, was significantly predictive of short term and long-term outcomes in PE patients who treated with thrombolytic agents. Our data suggest TRI to be an independent, feasible, and cost-effective tool for rapid risk stratification in moderate-high and high risk PE patients who treated with thrombolytic agents.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Muhammed MD, Tolga Sinan MD, Mert Ä°lker MD, Adnan MD, Mustafa Adem MD, Åahin MD, Ahmet MD, Taha MD, Ahmet Okan MD, Ãmer (Prof.),